\-\ Texto\\:\\ \ \(0\)\
\-\ a\\ pulse\\,\\ rather\\ than\\ a\\ thrill\\,\\ is\\ felt\\ in\\ the\\ region\\ of\\ the\\ left\\ arm\\ fistula\\.\\ \\ the\\ patients\\ left\\ arm\\ is\\ edematous\\.\\ \\ the\\ left\\ hand\\ is\\ warm\\ and\\ the\\ radial\\ pulse\\ can\\ be\\ palpated\\.\ \(0\)\
\-\ av\\ fistulas\\ for\\ dialysis\\ should\\ be\\ monitored\\ for\\:\ \(0\)\
\-\ 1\\.\\ venous\\ pressure\\ \\>140\\ mm\\ hg\\ at\\ a\\ dialyzer\\ flow\\ of\\ 200\\ ml\\/min\ \(0\)\
\-\ 2\\.\\ dialyzer\\ blood\\ flow\\ of\\ \\>200\\ to\\ ml\\/min\ \(0\)\
\-\ 3\\.\\ difficulties\\ in\\ fistula\\ access\ \(0\)\
\-\ a\\ fistulagram\\ should\\ be\\ performed\\ if\\ any\\ of\\ these\\ criteria\\ are\\ met\\.\ \(0\)\
\-\ reference\\:\ \(0\)\
\-\ peter\\ j\\ bosman\\,\\ frans\\ t\\ j\\ boereboom\\,\\ bert\\ c\\ eikelboom\\,\\ hein\\ a\\ koomans\\ and\\ peter\\ j\\ blankestijn\\.\\ graft\\ flow\\ as\\ a\\ predictor\\ of\\ thrombosis\\ in\\ hemodialysis\\ grafts\\.\\ kidney\\ international\\ \\(1998\\)\\ 54\\,\\ 1726\\â\\€\\“1730\ \(0\)\
\-\ chronic\\ left\\ brachiocephalic\\ vein\\ stenosis\ \(0\)\
\-\ sub\\-acute\\ complete\\ occlusion\ \(0\)\
\-\ angioplasty\\ and\\ stenting\\ of\\ the\\ occlusion\ \(0\)\
\-\ stent\\ placement\\ for\\ recurrent\\ central\\ venous\\ occlusion\ \(0\)\
\-\ central\\ venous\\ stenosis\\ or\\ central\\ venous\\ occlusion\\ can\\ be\\ due\\ to\\ a\\ number\\ of\\ disparate\\ primary\\ pathologies\\:\ \(0\)\
\-\ chronic\\ local\\ venous\\ hypertension\\ in\\ the\\ arm\\ of\\ a\\ dialysis\\ patient\\,\\ paget\\ schroder\\ syndrome\\ in\\ an\\ athlete\\ using\\ anabolic\\ steroids\\,\\ fibrosis\\ due\\ to\\ indwelling\\ pacemaker\\ leads\\,\\ and\\ superior\\ vena\\ cava\\ syndrome\\ due\\ to\\ cancer\\ are\\ some\\ of\\ the\\ more\\ common\\ of\\ these\\ processes\\.\ \(0\)\
\-\ lymphedema\\ \\(subsequent\\ to\\ axiallary\\ node\\ dissection\\ or\\ other\\ etiology\\)\ \(0\)\
\-\ 73\\ year\\ old\\ man\\ with\\ esrd\\ presents\\ with\\ severe\\ left\\ arm\\ swelling\\ following\\ regular\\ dialysis\\.\\ \\ \ \(0\)\
\-\ when\\ questioned\\ he\\ reports\\ that\\ the\\ size\\ of\\ his\\ arm\\ has\\ increased\\ significantly\\ over\\ the\\ preceding\\ 2\\ weeks\\.\ \(0\)\
\-\ venous\\ stent\\ patency\\ rate\\ are\\ lower\\ than\\ arterial\\ stent\\ patency\\ rates\\.\\ \\ stents\\ are\\ not\\ commonly\\ placed\\ for\\ central\\ venous\\ stenosis\\ or\\ occlusion\\.\ \(0\)\
\-\ in\\ this\\ case\\,\\ recurrent\\ severe\\ symptoms\\ were\\ present\\ that\\ were\\ refractory\\ to\\ multiple\\ venoplasty\\ procedures\\,\\ necessitating\\ stent\\ placement\\ as\\ a\\ last\\ resort\\ to\\ preserve\\ patency\\ of\\ the\\ fistula\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ venous\\:\\ 0\\.06849368873564639\ \(0\)\
\-\ occlusion\\:\\ 0\\.06721832069977851\ \(0\)\
\-\ stent\\:\\ 0\\.06067110711336312\ \(0\)\
\-\ arm\\:\\ 0\\.05645231011256386\ \(0\)\
\-\ patency\\:\\ 0\\.05607394321202209\ \(0\)\
\-\ dialyzer\\:\\ 0\\.05561841276950472\ \(0\)\
\-\ ml\\/min\\:\\ 0\\.05561841276950472\ \(0\)\
\-\ dialysis\\:\\ 0\\.05062885666719342\ \(0\)\
\-\ peter\\:\\ 0\\.04431393662295548\ \(0\)\
\-\ fistula\\:\\ 0\\.03965816035345956\ \(0\)\
\-\ 200\\:\\ 0\\.03704151069274485\ \(0\)\
\-\ j\\:\\ 0\\.03652704763121676\ \(0\)\
\-\ central\\:\\ 0\\.035477998193816515\ \(0\)\
\-\ stenosis\\:\\ 0\\.0316794159258489\ \(0\)\
\-\ pulse\\:\\ 0\\.027815767676354856\ \(0\)\
\-\ fistulagram\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ bosman\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ frans\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ boereboom\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ bert\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ eikelboom\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ hein\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ koomans\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ blankestijn\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ 1726\\â\\€\\“1730\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ schroder\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ venoplasty\\:\\ 0\\.02780920638475236\ \(0\)\
\-\ flow\\:\\ 0\\.026726061926105833\ \(0\)\
\-\ disparate\\:\\ 0\\.025622622218948114\ \(0\)\
\-\ anabolic\\:\\ 0\\.025622622218948114\ \(0\)\
\-\ axiallary\\:\\ 0\\.025622622218948114\ \(0\)\
\-\ lymphedema\\:\\ 0\\.024343552477281982\ \(0\)\
\-\ thrill\\:\\ 0\\.02343603805314387\ \(0\)\
\-\ recurrent\\:\\ 0\\.022750992246845913\ \(0\)\
\-\ predictor\\:\\ 0\\.02273211517833564\ \(0\)\
\-\ resort\\:\\ 0\\.02273211517833564\ \(0\)\
\-\ placement\\:\\ 0\\.021882718569394506\ \(0\)\
\-\ sub\\-acute\\:\\ 0\\.021670688564388595\ \(0\)\
\-\ esrd\\:\\ 0\\.021670688564388595\ \(0\)\
\-\ questioned\\:\\ 0\\.021670688564388595\ \(0\)\
\-\ due\\:\\ 0\\.021579909964853372\ \(0\)\
\-\ indwelling\\:\\ 0\\.021249453887339627\ \(0\)\
\-\ pathologies\\:\\ 0\\.020877898569811603\ \(0\)\
\-\ preceding\\:\\ 0\\.020877898569811603\ \(0\)\
\-\ preserve\\:\\ 0\\.020877898569811603\ \(0\)\
\-\ necessitating\\:\\ 0\\.020545531012531395\ \(0\)\
\-\ grafts\\:\\ 0\\.0202448679847575\ \(0\)\
\-\ hemodialysis\\:\\ 0\\.019970384145673495\ \(0\)\
\-\ brachiocephalic\\:\\ 0\\.019970384145673495\ \(0\)\
\-\ athlete\\:\\ 0\\.019717883490551927\ \(0\)\
\-\ pacemaker\\:\\ 0\\.01948410439858435\ \(0\)\
\-\ stents\\:\\ 0\\.01926646127086526\ \(0\)\
\-\ 140\\:\\ 0\\.019062869721535383\ \(0\)\
\-\ met\\:\\ 0\\.018871624857761143\ \(0\)\
\-\ international\\:\\ 0\\.018871624857761143\ \(0\)\
\-\ hg\\:\\ 0\\.018691314404007363\ \(0\)\
\-\ fistulas\\:\\ 0\\.018520755346372424\ \(0\)\
\-\ \\>\\:\\ 0\\.017912728799170753\ \(0\)\
\-\ stenting\\:\\ 0\\.017531299324747684\ \(0\)\
\-\ difficulties\\:\\ 0\\.017412244662341227\ \(0\)\
\-\ angioplasty\\:\\ 0\\.017297520232780108\ \(0\)\
\-\ should\\:\\ 0\\.017187435595512935\ \(0\)\
\-\ warm\\:\\ 0\\.017186822063028465\ \(0\)\
\-\ 1998\\:\\ 0\\.017186822063028465\ \(0\)\
\-\ access\\:\\ 0\\.017079877105061016\ \(0\)\
\-\ av\\:\\ 0\\.01697643917817461\ \(0\)\
\-\ refractory\\:\\ 0\\.016685040691956896\ \(0\)\
\-\ be\\:\\ 0\\.016627845089513302\ \(0\)\
\-\ 73\\:\\ 0\\.016593597357971876\ \(0\)\
\-\ severe\\:\\ 0\\.016588705363192454\ \(0\)\
\-\ edematous\\:\\ 0\\.01650473023820312\ \(0\)\
\-\ palpated\\:\\ 0\\.01633417118056818\ \(0\)\
\-\ monitored\\:\\ 0\\.016252229583081552\ \(0\)\
\-\ graft\\:\\ 0\\.015944221792659103\ \(0\)\
\-\ rates\\:\\ 0\\.01566363035412126\ \(0\)\
\-\ syndrome\\:\\ 0\\.015418968938388905\ \(0\)\
\-\ chronic\\:\\ 0\\.015186054466290221\ \(0\)\
\-\ left\\:\\ 0\\.015080524751938718\ \(0\)\
\-\ leads\\:\\ 0\\.015055101438902044\ \(0\)\
\-\ paget\\:\\ 0\\.014946312239939365\ \(0\)\
\-\ criteria\\:\\ 0\\.01473938074944784\ \(0\)\
\-\ are\\:\\ 0\\.014698723943591188\ \(0\)\
\-\ processes\\:\\ 0\\.014592629911482878\ \(0\)\
\-\ procedures\\:\\ 0\\.014592629911482878\ \(0\)\
\-\ reference\\:\\ 0\\.014498456526152654\ \(0\)\
\-\ vena\\:\\ 0\\.014274634015199076\ \(0\)\
\-\ 54\\:\\ 0\\.014231713977168227\ \(0\)\
\-\ cava\\:\\ 0\\.014189370064448543\ \(0\)\
\-\ than\\:\\ 0\\.014126491198222547\ \(0\)\
\-\ these\\:\\ 0\\.01403056587986019\ \(0\)\
\-\ significantly\\:\\ 0\\.01379453365134442\ \(0\)\
\-\ number\\:\\ 0\\.0134436641399557\ \(0\)\
\-\ dissection\\:\\ 0\\.013250466583991288\ \(0\)\
\-\ rather\\:\\ 0\\.01281365373141998\ \(0\)\
\-\ c\\:\\ 0\\.01281365373141998\ \(0\)\
\-\ felt\\:\\ 0\\.01268052958476264\ \(0\)\
\-\ steroids\\:\\ 0\\.01268052958476264\ \(0\)\
\-\ t\\:\\ 0\\.012478567885188726\ \(0\)\
\-\ regular\\:\\ 0\\.012430035018187213\ \(0\)\
\-\ local\\:\\ 0\\.012382237526008658\ \(0\)\
\-\ radial\\:\\ 0\\.012358607646736866\ \(0\)\
\-\ node\\:\\ 0\\.012335153455924506\ \(0\)\
\-\ were\\:\\ 0\\.012241554174699819\ \(0\)\
\-\ can\\:\\ 0\\.012228532192233877\ \(0\)\
\-\ fibrosis\\:\\ 0\\.012002785898644298\ \(0\)\
\-\ arterial\\:\\ 0\\.01179919434931442\ \(0\)\
\-\ using\\:\\ 0\\.011702122870870402\ \(0\)\
\-\ thrombosis\\:\\ 0\\.011571053461050616\ \(0\)\
\-\ last\\:\\ 0\\.011516506151555155\ \(0\)\
\-\ etiology\\:\\ 0\\.011410162122084141\ \(0\)\
\-\ a\\:\\ 0\\.011259931281916125\ \(0\)\
\-\ hand\\:\\ 0\\.011079537905070734\ \(0\)\
\-\ placed\\:\\ 0\\.010911457884209733\ \(0\)\
\-\ reports\\:\\ 0\\.010867130586242382\ \(0\)\
\-\ \\:\\:\\ 0\\.010696607091394306\ \(0\)\
\-\ hypertension\\:\\ 0\\.010627069565615734\ \(0\)\
\-\ pressure\\:\\ 0\\.01058653914770454\ \(0\)\
\-\ rate\\:\\ 0\\.010507007856390672\ \(0\)\
\-\ subsequent\\:\\ 0\\.010493945418958395\ \(0\)\
\-\ commonly\\:\\ 0\\.010172023480932622\ \(0\)\
\-\ mm\\:\\ 0\\.009912287560867525\ \(0\)\
\-\ vein\\:\\ 0\\.009753732877016143\ \(0\)\
\-\ kidney\\:\\ 0\\.009496477776182996\ \(0\)\
\-\ complete\\:\\ 0\\.009486990328031717\ \(0\)\
\-\ or\\:\\ 0\\.009478133270949913\ \(0\)\
\-\ to\\:\\ 0\\.00943052605394607\ \(0\)\
\-\ \\,\\:\\ 0\\.00939372467094688\ \(0\)\
\-\ that\\:\\ 0\\.009312181252737056\ \(0\)\
\-\ 3\\.\\:\\ 0\\.009223577956279896\ \(0\)\
\-\ for\\:\\ 0\\.009200102821990096\ \(0\)\
\-\ size\\:\\ 0\\.009037463316652275\ \(0\)\
\-\ swelling\\:\\ 0\\.008980475911612405\ \(0\)\
\-\ cancer\\:\\ 0\\.008861720076860459\ \(0\)\
\-\ superior\\:\\ 0\\.008608024280928049\ \(0\)\
\-\ 2\\.\\:\\ 0\\.008572378996215326\ \(0\)\
\-\ any\\:\\ 0\\.008488438590133419\ \(0\)\
\-\ 1\\.\\:\\ 0\\.008420155098730602\ \(0\)\
\-\ some\\:\\ 0\\.008185893545321007\ \(0\)\
\-\ as\\:\\ 0\\.008155063128669576\ \(0\)\
\-\ primary\\:\\ 0\\.00798543931512838\ \(0\)\
\-\ in\\:\\ 0\\.007975972810225645\ \(0\)\
\-\ his\\:\\ 0\\.007769366017813665\ \(0\)\
\-\ when\\:\\ 0\\.007720287815823361\ \(0\)\
\-\ following\\:\\ 0\\.007650718476028859\ \(0\)\
\-\ weeks\\:\\ 0\\.007650718476028859\ \(0\)\
\-\ region\\:\\ 0\\.007613883997600355\ \(0\)\
\-\ he\\:\\ 0\\.00752109571619249\ \(0\)\
\-\ performed\\:\\ 0\\.007516019972325927\ \(0\)\
\-\ blood\\:\\ 0\\.007357763635676023\ \(0\)\
\-\ if\\:\\ 0\\.007314648056090332\ \(0\)\
\-\ common\\:\\ 0\\.007054470700177909\ \(0\)\
\-\ patients\\:\\ 0\\.006976576023236675\ \(0\)\
\-\ over\\:\\ 0\\.006863225836403667\ \(0\)\
\-\ more\\:\\ 0\\.006741881101931124\ \(0\)\
\-\ symptoms\\:\\ 0\\.00671816238769129\ \(0\)\
\-\ increased\\:\\ 0\\.006594589217033614\ \(0\)\
\-\ man\\:\\ 0\\.006375179315741322\ \(0\)\
\-\ other\\:\\ 0\\.006213370816096052\ \(0\)\
\-\ present\\:\\ 0\\.006088355690636217\ \(0\)\
\-\ lower\\:\\ 0\\.006062656370233005\ \(0\)\
\-\ case\\:\\ 0\\.005897490324502431\ \(0\)\
\-\ 2\\:\\ 0\\.005804746045774594\ \(0\)\
\-\ multiple\\:\\ 0\\.005677621462079712\ \(0\)\
\-\ presents\\:\\ 0\\.005506764339141722\ \(0\)\
\-\ is\\:\\ 0\\.005321363833293934\ \(0\)\
\-\ has\\:\\ 0\\.005062145017332107\ \(0\)\
\-\ the\\:\\ 0\\.004797293790977551\ \(0\)\
\-\ \\(\\:\\ 0\\.004557487231822464\ \(0\)\
\-\ \\)\\:\\ 0\\.0045018150921975085\ \(0\)\
\-\ of\\:\\ 0\\.00441023851601218\ \(0\)\
\-\ not\\:\\ 0\\.0038953270401953797\ \(0\)\
\-\ an\\:\\ 0\\.0037276494141474125\ \(0\)\
\-\ at\\:\\ 0\\.003652249693475183\ \(0\)\
\-\ this\\:\\ 0\\.0030319785908963187\ \(0\)\
\-\ year\\:\\ 0\\.0030161049503877437\ \(0\)\
\-\ old\\:\\ 0\\.002760046046884084\ \(0\)\
\-\ patient\\:\\ 0\\.002702182747370309\ \(0\)\
\-\ and\\:\\ 0\\.0022714070123939236\ \(0\)\
\-\ \\.\\:\\ 0\\.0012318451011697445\ \(0\)\
\-\ with\\:\\ 0\\.0007381966945734368\ \(0\)\
